4-((3-Allyl-2-hydroxybenzylidene)amino)-3-(2-chlorophenyl)-1H-1,2,4-triazole-5(4H)-thione

Catalog No. :
ACVCNF817
CAS No. :
478254-30-7
Molecular Formula :
C18H15ClN4OS
Molecular Weight :
370.86

IUPAC Name:(E)-4-((3-allyl-2-hydroxybenzylidene)amino)-5-(2-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

4-((3-Allyl-2-hydroxybenzylidene)amino)-3-(2-chlorophenyl)-1H-1,2,4-triazole-5(4H)-thione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((3-Allyl-2-hydroxybenzylidene)amino)-3-(2-chlorophenyl)-1H-1,2,4-triazole-5(4H)-thione
IUPAC Name(E)-4-((3-allyl-2-hydroxybenzylidene)amino)-5-(2-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
Molecular FormulaC18H15ClN4OS
Molecular Weight370.86
SMILESS=C1NN=C(C2=CC=CC=C2Cl)N1/N=C/C3=CC=CC(CC=C)=C3O
InChI KeyHAGCRBJGMNFWPG-RGVLZGJSSA-N
SynonymSALOR-INT L228923-1EA;2-ALLYL-6-(((3-(2-CHLOROPHENYL)-5-MERCAPTO-4H-1,2,4-TRIAZOL-4-YL)IMINO)ME)PHENOL;(E)-2-allyl-6-(((3-(2-chlorophenyl)-5-mercapto-4H-1,2,4-triazol-4-yl)imino)methyl)phenol;3H-1,2,4-Triazole-3-thione, 5-(2-chlorophenyl)-2,4-dihydro-4-[[[2-hydroxy-3-(2-propen-1-yl)phenyl]methylene]amino]-
CAS No.478254-30-7

Synthetic Route by SureRoute

1. ACVCNF817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVMYI832 route compound structure diagram
    ACVMYI83224019-66-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVCNF817 route product structure diagram
    ACVCNF817478254-30-7
Inquiry

2. ACVCNF817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVCNF817 route product structure diagram
    ACVCNF817478254-30-7
Inquiry

Comments (0)